Outset Medical Stock Price, News & Analysis (NASDAQ:OM) $5.69 +0.45 (+8.59%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$5.19▼$5.7050-Day Range$3.07▼$11.0152-Week Range$2.90▼$30.55Volume807,822 shsAverage Volume1.41 million shsMarket Capitalization$285.69 millionP/E RatioN/ADividend YieldN/APrice Target$7.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Outset Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.20 Rating ScoreUpside/Downside36.2% Upside$7.75 Price TargetShort InterestHealthy15.91% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.18Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.45) to ($2.25) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.89 out of 5 starsMedical Sector707th out of 955 stocksElectromedical Equipment Industry17th out of 23 stocks 3.1 Analyst's Opinion Consensus RatingOutset Medical has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.75, Outset Medical has a forecasted upside of 36.2% from its current price of $5.69.Amount of Analyst CoverageOutset Medical has only been the subject of 4 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted15.91% of the outstanding shares of Outset Medical have been sold short.Short Interest Ratio / Days to CoverOutset Medical has a short interest ratio ("days to cover") of 6.1.Change versus previous monthShort interest in Outset Medical has recently decreased by 5.11%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldOutset Medical does not currently pay a dividend.Dividend GrowthOutset Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OM. Previous Next 3.4 News and Social Media Coverage News SentimentOutset Medical has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Outset Medical this week, compared to 2 articles on an average week.Search InterestOnly 5 people have searched for OM on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows4 people have added Outset Medical to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Outset Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.70% of the stock of Outset Medical is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Outset Medical are expected to grow in the coming year, from ($3.45) to ($2.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Outset Medical is -1.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Outset Medical is -1.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOutset Medical has a P/B Ratio of 1.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Outset Medical Stock (NASDAQ:OM)Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.Read More OM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OM Stock News HeadlinesDecember 2, 2023 | americanbankingnews.comOutset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Hold" by AnalystsNovember 29, 2023 | finance.yahoo.comOutset Medical to Present at BofA Home Care ConferenceDecember 3, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 14, 2023 | benzinga.comOutset Medical Stock (NASDAQ:OM), Analyst Ratings, Price Targets, PredictionsNovember 9, 2023 | benzinga.comOutset Medical Stock (NASDAQ:OM) Earnings Dates and Earning CallsNovember 9, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Ascend Wellness Holdings LLC (OtherAAWH), Vertex Pharmaceuticals (VRTX) and Outset Medical (OM)November 7, 2023 | benzinga.comRecap: Outset Medical Q3 EarningsNovember 7, 2023 | finance.yahoo.comOutset Medical Reports Third Quarter 2023 Financial ResultsDecember 3, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 6, 2023 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Outset Medical (OM)November 6, 2023 | benzinga.comA Preview Of Outset Medical's EarningsNovember 2, 2023 | finance.yahoo.comAfter Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM)November 2, 2023 | finance.yahoo.comAnalysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out forNovember 1, 2023 | finance.yahoo.comNew Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo® Hemodialysis System on Equitable Kidney CareOctober 30, 2023 | finance.yahoo.comOutset Medical to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023October 27, 2023 | benzinga.comHagens Berman Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law ViolationsOctober 23, 2023 | barrons.comCalling All Outset Medical, Inc. (OM) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Claim Your LossesOctober 17, 2023 | finance.yahoo.comDown -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM)October 16, 2023 | finance.yahoo.comOutset Medical, Inc. (NASDAQ:OM) Q3 2023 Earnings Call TranscriptOctober 14, 2023 | nasdaq.comStifel Maintains Outset Medical (OM) Buy RecommendationOctober 14, 2023 | msn.comB of A Securities Downgrades Outset Medical (OM)October 13, 2023 | benzinga.comWhy Outset Medical Shares Are Plummeting TodayOctober 13, 2023 | msn.comOutset tumbles ~40% after Bofa downgrades following guidance cutOctober 12, 2023 | seekingalpha.comOutset Medical expects higher 2023 revenue year on yearOctober 12, 2023 | finance.yahoo.comOutset Medical Reports Preliminary Third Quarter 2023 Financial ResultsOctober 12, 2023 | msn.comDialysis stocks decline again as Novo Nordisk hits 52-week highOctober 11, 2023 | msn.comBaxter, Outset hit new 52-week lows amid dialysis stocks sell-offSee More Headlines Receive OM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/07/2023Today12/02/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/12/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:OM CUSIPN/A CIK1484612 Weboutsetmedical.com Phone669-231-8200FaxN/AEmployees518Year FoundedN/APrice Target and Rating Average Stock Price Target$7.75 High Stock Price Target$17.00 Low Stock Price Target$3.00 Potential Upside/Downside+36.2%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-162,960,000.00 Net Margins-133.19% Pretax Margin-132.83% Return on Equity-88.10% Return on Assets-50.01% Debt Debt-to-Equity Ratio0.64 Current Ratio5.35 Quick Ratio4.44 Sales & Book Value Annual Sales$115.38 million Price / Sales2.48 Cash FlowN/A Price / Cash FlowN/A Book Value$3.03 per share Price / Book1.88Miscellaneous Outstanding Shares50,210,000Free Float48,347,000Market Cap$285.69 million OptionableNot Optionable Beta2.07 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMs. Leslie L. Trigg (Age 52)President, CEO & Chairman Comp: $1.22MMr. Nabeel Ahmed (Age 47)CFO, Principal Financial Officer & Principal Accounting Officer Comp: $654.74kMr. John L. Brottem (Age 49)General Counsel & Secretary Comp: $594.15kMr. Steven S. Williamson (Age 50)Chief Commercial Officer Comp: $788.51kMarc NashSenior Vice President of Operations and R&DMr. Jean-Olivier Racine (Age 41)Chief Technology Officer Comp: $540.93kMr. James S. MazzolaHead of Investor RelationsNicole ShannonDirector of Marketing CommunicationsMs. Stacey L. Porter (Age 47)Chief People Officer Dr. Michael Aragon M.D.Chief Medical OfficerMore ExecutivesKey CompetitorsSemler ScientificNASDAQ:SMLRAxoGenNASDAQ:AXGNEdap TmsNASDAQ:EDAPZynexNASDAQ:ZYXIFONARNASDAQ:FONRView All CompetitorsInsiders & InstitutionsDeutsche Bank AGSold 133,964 shares on 11/24/2023Ownership: 0.058%Graham Capital Management L.P.Bought 10,223 shares on 11/22/2023Ownership: 0.020%Morgan StanleyBought 1,051,089 shares on 11/16/2023Ownership: 3.185%Tudor Investment Corp Et AlBought 124,344 shares on 11/16/2023Ownership: 0.248%Horizon Family Wealth Inc.Bought 28,710 shares on 11/16/2023Ownership: 0.057%View All Insider TransactionsView All Institutional Transactions OM Stock Analysis - Frequently Asked Questions Should I buy or sell Outset Medical stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares. View OM analyst ratings or view top-rated stocks. What is Outset Medical's stock price target for 2024? 5 brokerages have issued 12 month price objectives for Outset Medical's shares. Their OM share price targets range from $3.00 to $17.00. On average, they expect the company's stock price to reach $7.75 in the next twelve months. This suggests a possible upside of 36.2% from the stock's current price. View analysts price targets for OM or view top-rated stocks among Wall Street analysts. How have OM shares performed in 2023? Outset Medical's stock was trading at $25.82 at the beginning of 2023. Since then, OM stock has decreased by 78.0% and is now trading at $5.69. View the best growth stocks for 2023 here. When is Outset Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 12th 2024. View our OM earnings forecast. How were Outset Medical's earnings last quarter? Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.93) EPS for the quarter, missing the consensus estimate of ($0.79) by $0.14. The firm had revenue of $30.36 million for the quarter, compared to analysts' expectations of $30.38 million. Outset Medical had a negative trailing twelve-month return on equity of 88.10% and a negative net margin of 133.19%. What ETFs hold Outset Medical's stock? ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT), Procure Disaster Recovery Strategy ETF (FEMA), BNY Mellon Innovators ETF (BKIV), SPDR S&P Health Care Equipment ETF (XHE) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Medical Devices ETF (IHI). What guidance has Outset Medical issued on next quarter's earnings? Outset Medical updated its third quarter 2023 earnings guidance on Thursday, October, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $30.40 million-$30.40 million, compared to the consensus revenue estimate of $36.03 million. When did Outset Medical IPO? (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Outset Medical's major shareholders? Outset Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include FMR LLC (14.87%), JPMorgan Chase & Co. (10.17%), Braidwell LP (4.78%), Ameriprise Financial Inc. (3.49%), Morgan Stanley (3.19%) and Eagle Health Investments LP (3.00%). Insiders that own company stock include D Keith Grossman, James F Hinrichs, James F Hinrichs, Jean-Olivier Racine, John L Brottem, John L Brottem, Leslie Trigg, Martin Vazquez, Nabeel Ahmed, Pincus X LP Warburg, Rebecca Chambers, Stacey L Porter, Steven S Williamson and Warburg Pincus Llc. View institutional ownership trends. How do I buy shares of Outset Medical? Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:OM) was last updated on 12/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.